Hypogonadism

Latest

JAMA: Testosterone Trial Results Highlight Benefits and Risk of Testosterone Treatment

JAMA: Testosterone Trial Results Highlight Benefits and Risk of Testosterone Treatment

Studies published in JAMA and JAMA Internal Medicine highlight the benefits and risks of treating men for low testosterone.

Harmonized Testosterone Reference Ranges Established for Men

Harmonized Testosterone Reference Ranges Established for Men

Researchers have pinpointed harmonized references ranges for total testosterone levels in men.

Venous Thromboembolism Risk Higher in Men Starting Testosterone Therapy

Venous Thromboembolism Risk Higher in Men Starting Testosterone Therapy

Starting testosterone treatment is associated with an increased risk of venous thromboembolism (VTE), peaking within 6 months and declining thereafter.

Implantable Testosterone Pellets Associated With Small Hematocrit Increase

Implantable Testosterone Pellets Associated With Small Hematocrit Increase

Men treated with implantable testosterone pellets have a statistically significant increase in mean hematocrit, but it is unlikely to be clinically relevant.

Once-Daily Testosterone Solution Beneficial in Androgen Deficiency

Once-Daily Testosterone Solution Beneficial in Androgen Deficiency

Once-daily testosterone solution 2% (T-sol) is safe and improves sex drive and energy in men with androgen deficiency.

Testosterone Solution Found Safe, Effective for Hypogonadal Men

Testosterone Solution Found Safe, Effective for Hypogonadal Men

Once-daily 2% testosterone solution (T-sol) is safe and effective for sex drive and energy in hypogonadal men.

Testosterone Gel Moderately Improved Sexual Function in Older Men

Testosterone Gel Moderately Improved Sexual Function in Older Men

Men using testosterone gel experienced improvements in sex drive, sexual activity, and erectile function.

Testosterone Undecanoate May Reduce Anemia in Men With Hypogonadism

Testosterone Undecanoate May Reduce Anemia in Men With Hypogonadism

Results showed a decreased prevalence of anemia and components of metabolic syndrome after 54 weeks of treatment.

Low Testosterone, Sarcopenia Predicted Mortality in Advanced Liver Disease

Low Testosterone, Sarcopenia Predicted Mortality in Advanced Liver Disease

Both low testosterone and sarcopenia tied to increased mortality, with low testosterone being a better predictor.

Topical Testosterone Effectively Restores Normal Testosterone Levels in Men

Topical Testosterone Effectively Restores Normal Testosterone Levels in Men

Daily topical testosterone restored normal testosterone levels in hypogonadal men

Sign Up for Free e-Newsletters